Risks of bacterial and fungal superinfection in patients with COVID-19 stratified by new and pre-existing immunosuppression: a retrospective, observation, multisite, multinational cohort study - UQ Researchers

Risks of bacterial and fungal superinfection in patients with COVID-19 stratified by new and pre-existing immunosuppression: a retrospective, observation, multisite, multinational cohort study (2021–2024)

Grant type:: Merck Sharp & Dohme Australia
Funded by:: Merck, Sharp & Dohme

The University of Queensland

Brisbane St Lucia, QLD 4072

+61 7 3365 1111

Other Campuses: UQ Gatton, UQ Herston

Maps and Directions

© 2024 The University of Queensland

A Member of

Privacy & Terms of use | Feedback

Authorised by: Director of OMC

ABN 63 942 912 684

CRICOS Provider No:00025B

Explore

Need Help?

Emergency

Ph. 3365 3333